-
Lawmakers want to expand the authority to negotiate drug prices with companies.
-
Move could help reduce drug costs for the state.
-
The plan allows the state to set upper payment limits on drugs.
-
Board approves structure to put upper payment limits on some drugs.
-
Maryland's Prescription Drug Affordability Board is tasked with reducing the cost of medication. The five member board has several tools at its disposal.
-
Some Inflation Reduction Act provisions will expire in 2025.
-
The next step is for the board to conduct cost reviews of the drugs.
-
The suit claims the companies conspired to increase the cost of insulin.
-
A new bill would allow the board to review drugs for the whole state.
-
The White House says it will take over patents of federally funded drugs priced too high.